These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. Bretton PR; Herr HW; Kimmel M; Whitmore WF; Laudone V; Oettgen HF; Fair WR J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796 [TBL] [Abstract][Full Text] [Related]
14. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. Hillyard RW; Ladaga L; Schellhammer PF J Urol; 1988 Feb; 139(2):290-3. PubMed ID: 3339727 [TBL] [Abstract][Full Text] [Related]
15. Histological parameters and pitfalls in the interpretation of bladder biopsies in bacillus Calmette-Guerin treatment of superficial bladder cancer. Lage JM; Bauer WC; Kelley DR; Ratliff TL; Catalona WJ J Urol; 1986 May; 135(5):916-9. PubMed ID: 3959240 [TBL] [Abstract][Full Text] [Related]
16. Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. Böhle A; Gerdes J; Ulmer AJ; Hofstetter AG; Flad HD J Urol; 1990 Jul; 144(1):53-8. PubMed ID: 2359181 [TBL] [Abstract][Full Text] [Related]
17. Long term protection in bladder cancer following intralesional immunotherapy. Reichert DF; Lamm DL J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762 [TBL] [Abstract][Full Text] [Related]
18. Intravesical bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder. Pansadoro V; De Paula F J Urol; 1987 Aug; 138(2):299-301. PubMed ID: 3599242 [TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder. Schellhammer PF; Ladaga LE; Fillion MB J Urol; 1986 Feb; 135(2):261-4. PubMed ID: 3511283 [TBL] [Abstract][Full Text] [Related]
20. A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer. Lamm DL; DeHaven JI; Shriver J; Crispen R; Grau D; Sarosdy MF J Urol; 1990 Jul; 144(1):65-7. PubMed ID: 2193172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]